Armed Forces Institute of Regenerative Medicine | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 537,504 条关于 “Armed Forces Institute of Regenerative Medicine”

Neuraptive Therapeutics Initiates Phase 3 Trial for NTX-001 in Traumatic Peripheral Nerve Injuries

Conexeu Sciences Initiates Preclinical 3D-Bioprinted Breast Matrix Program with Wake Forest Institute for Regenerative Medicine

3D Bioprinting of Cartilage Tissue on the ISS Advances Regenerative Medicine

The Next Era of Aesthetic Medicine: From Treatment Stacking to Regenerative Science

Harvard Apparatus Regenerative Technology and Capital Institute of Pediatrics Collaborate on Esophageal Atresia Treatment

MeiraGTx's AAV2-hAQP1 Receives FDA RMAT Designation for Radiation-Induced Xerostomia

Harvard Apparatus Regenerative Technology Partners with Capital Institute of Pediatrics for Esophageal Atresia Treatment

ZEO ScientifiX Advances Regenerative Medicine Portfolio with Successful Phase I Completion of Zofin™

BridgeBio's BBP-812 Receives FDA RMAT Designation for Canavan Disease Gene Therapy

Allogene's ALLO-316 Receives FDA RMAT Designation for Advanced Renal Cell Carcinoma

第 1 页，共 4080 页